Gupta Suneel - Insider Non-Derivative Transactions at Protagonist Therapeutics, Inc (PTGX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 26, 2024, Gupta Suneel's relationship to Protagonist Therapeutics, Inc (PTGX) is Officer (Chief Development Officer), and currently has 183,285 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other PTGX insiders.
Data Source: SEC.
Gupta Suneel - Insider Non-Derivative Transactions of PTGX Common Stock
Gupta Suneel - Insider Non-Derivative Transactions at PTGX
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
Feb 27, 2024 | F -- (Common Stock) | 4282 | 29.53 | 183285 |
Jan 10, 2024 | Sell -- (Common Stock) | 5000 | 25 | 187567 |
Jan 10, 2024 | M -- (Common Stock) | 5000 | 7.38 | 192567 |
Jan 3, 2024 | Acquisition -- (Common Stock) | 19250 | 0 | 187567 |
Oct 20, 2023 | M -- (Common Stock) | 20000 | 7.38 | 168317 |
Jun 1, 2023 | F -- (Common Stock) | 4150 | 26.07 | 148037 |
Jun 1, 2023 | Acquisition -- (Common Stock) | 12000 | 0 | 152187 |
Jan 17, 2023 | Acquisition -- (Common Stock) | 20625 | 0 | 138187 |